Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ib Study of Copanlisib in Combination With Nivolumab or With Nivolumab and Ipilimumab

Next Previous
Trial Profile

Phase Ib Study of Copanlisib in Combination With Nivolumab or With Nivolumab and Ipilimumab

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Mar 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Copanlisib (Primary) ; Nivolumab (Primary)
  • Indications Lymphoma; Solid tumours
  • Focus Adverse reactions

    • Most Recent Events

    • 04 Jul 2023 Planned End Date changed from 1 Jul 2023 to 1 Jul 2024.
    • 04 Jul 2023 Planned primary completion date changed from 1 Jul 2023 to 1 Jul 2024.
    • 14 Feb 2023 According to ClinicalTrials.gov record, protocol has been amended to increase patient number from 48 to 64, treatment arm changed from 1 to 2. Study design changed from Single Group Assignment to Sequential Assignment.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top